Clinical Trial Update: Patient Derived Breast Cancer Xenografts

View source ↗

Summary

A clinical trial involving patient-derived xenografts for metastatic breast cancer conducted by Dartmouth-Hitchcock Medical Center has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Metastatic Breast Cancer | Status: TERMINATED